A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
Clinical trial NCT02494778 · TERMINATED
Trial details
- NCT number
- NCT02494778
- Sponsor
- Prilenia
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-24
- Primary completion
- 2018-01-12
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.